Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experience.

Faber, Mark G; Wang, Chong; Kommi Reddy, Sruthi; Meagher, Alison; Early, Amy; Chen, Hongbin; Dy, Grace K

Faber, Mark G; Wang, Chong; Kommi Reddy, Sruthi; Meagher, Alison; Early, Amy; Chen, Hongbin; Dy, Grace K.

Afiliación

Faber MG; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Mark.Faber@Roswellpark.org.
Wang C; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Chong.Wang@Roswellpark.org.
Kommi Reddy S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Meagher A; Department of Pharmacy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Alison.Meagher@Roswellpark.org.
Early A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Amy.Early@Roswellpark.org.
Chen H; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Hongbin.Chen@Roswellpark.org.
Dy GK; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Electronic address: Grace.Dy@Roswellpark.org.

Lung Cancer ; 165: 49-53, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35085984

Palabras clave

Chemotherapy; Cytopenia; Maintenance chemotherapy; Non-small cell lung cancer; Pemetrexed; Toxicities

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google